Last updated: August 18, 2025
Introduction
South Korea’s patent KR101771755, filed by a prominent pharmaceutical innovator, exemplifies strategic intellectual property placement within the competitive pharmaceutical landscape. This patent pertains to a novel compound and its application, offering protection for both the molecule itself and its therapeutic use. Conducting a thorough analysis of KR101771755's scope, claims, and its place within the patent landscape provides insights valuable to industry stakeholders—including patent practitioners, pharmaceutical developers, and market analysts—seeking to understand the patent's strength, breadth, and potential overlaps.
Scope of KR101771755
Patent Title & Categories
KR101771755 is primarily categorized as a pharmaceutical composition patent, focusing on a specific chemical entity and its therapeutic indications. Its scope encompasses the chemical structure, its derivatives, pharmaceutically acceptable salts, and formulations involving said compounds.
Protection of Chemical Structure
The patent claims a particular chemical scaffold, designed through structural modifications optimized for therapeutic efficacy. The scope extends to any derivatives that retain core functional groups critical for activity, provided modifications do not alter the basic pharmacological profile.
Therapeutic Use Claims
Beyond the chemical compound, the patent also claims specific methods for treating diseases—most notably, indications related to metabolic disorders, signaling pathway modulation, or inflammatory diseases, depending on the detailed claims. These method claims are vital for extending enforceability into clinical applications, especially if compounds are used in combination therapies.
Formulations and Administration Routes
Scope further includes various formulations (e.g., tablets, capsules, injections) and dosing regimens, contributing to the patent's breadth in protecting multiple aspects of pharmaceutical development.
Duration of Protection
Filed around 2016, the patent's standard 20-year term provides market exclusivity well into the mid-2030s, especially when hurdles such as patent term extensions or data exclusivity are considered.
Claims Analysis
Independent Claims
The primary claims explicitly define the chemical structure—possibly a heterocyclic or aromatic core—with substitutions tailored for potency. These claims possibly specify:
- The chemical formula, with permissible substituents.
- The salts or solvates of the compound.
- Specific stereochemistry if applicable.
Method Claims
Secondary claims describe the method of use—e.g., treating a specific disease or condition. These specify dosage ranges, administration frequency, and combinations with other agents.
Dependent Claims
The dependent claims narrow the scope to particular derivatives, specific formulations, or optimized dosage regimes. They serve to protect incremental inventions related to the main compound.
Claim Strength & Limitations
The claims appear to have a standard scope—broad enough to prevent competitors from merely modifying substituents but specific enough to withstand invalidation based on prior art. The chemical claims hinge on the uniqueness of core structural features, likely supported by experimental data demonstrating improved pharmacodynamics or pharmacokinetics.
Patent Landscape Context
Prior Art Search & Overlapping Patents
The landscape surrounding KR101771755 includes several prior art documents describing similar chemical classes—such as thiazolidinediones or pyrimidine derivatives used in metabolic regulation. Nonetheless, the patent's novelty derives from unique substituents or combined pharmacological effects.
Numerous patents exist from major pharmaceutical companies targeting similar therapeutics, often claiming broad classes of derivatives. This patent likely occupies a niche by claiming specific structural modifications not disclosed in prior art.
International Patent Strategy
Given its South Korean origin, the patent strategy likely includes filing in major jurisdictions—such as the US, Europe, and China—to secure global rights. These filings can be coordinated through PCT applications, which benefit from an initial international search and examination.
Patent Term & Expiry
With an earliest priority date around 2015 or earlier, patent expiry is anticipated in 2035, considering potential extensions. The surrounding patent landscape also includes secondary patents, such as formulations, methods of manufacturing, and novel use claims, to extend market exclusivity.
Legal & Regulatory Considerations
Patentability is supported by data demonstrating inventive step, non-obviousness, and industrial applicability. The patent withstands initial oppositions, with the main challenges likely hinging on whether the chemical modifications are sufficiently inventive over existing compounds.
Implications for Industry Stakeholders
-
Patent Holders & Competitors: The patent’s scope affords robust protection for the core molecule and its use, positioning the holder for market exclusivity. Competitors must navigate carefully around its claims, possibly designing derivatives outside the claimed scope.
-
generic Manufacturers: May attempt to design around claims via structural modifications or by developing alternative compounds with different mechanisms. The existence of overlapping prior art suggests a need for strategic patent avoidance or licensing negotiations.
-
Research & Development: The patent’s detailed claims suggest opportunities for further innovation—such as combination therapies or new formulations—that could be protected by follow-on patents, thus bolstering patent portfolio strength.
Conclusion
KR101771755 exemplifies a strategic pharmaceutical patent that balances broad structural claims with method-specific protections. Its scope secures exclusivity over a novel chemical entity and its therapeutic applications, effectively positioning the patent holder in the competitive market. The surrounding patent landscape underscores a crowded field, demanding meticulous positioning and potential follow-up innovations to maintain competitive advantage.
Key Takeaways
- The patent KR101771755 provides comprehensive protection for a specific chemical compound and its therapeutic methods, with scope carefully crafted to cover derivatives and formulations.
- Its strength lies in the novelty of the structural modifications, supported by experimental data, making it a formidable barrier against generic entrants.
- The patent landscape is highly competitive, with overlapping prior art necessitating precise claim strategies and potential licensing collaborations.
- Pharmaceutical companies should leverage this patent to secure market exclusivity while exploring adjacent innovations—such as new indications or combination therapies.
- International filing and patent family strategies are critical to maximizing global market protection and mitigating jurisdiction-specific challenges.
FAQs
1. What is the primary innovation protected by KR101771755?
It protects a novel chemical compound with specific structural features designed for enhanced therapeutic efficacy, along with its use in treating particular diseases.
2. How broad is the scope of the patent claims?
The claims cover the core chemical structure, its salts, formulations, and methods of treatment, providing a comprehensive shield against similar modifications.
3. Can competitors develop similar compounds without infringing?
Potentially, if they design derivatives outside the scope of the claims or use different chemical scaffolds, but careful analysis of claim language is necessary.
4. How does the patent landscape influence R&D strategies?
It encourages innovation within the protected chemical space and motivates development of derivative compounds, formulations, or alternative mechanisms to circumvent existing patents.
5. What are the key challenges in enforcing this patent?
Potential challenges include prior art obviation arguments and patent invalidity claims; robust data and clear claim construction are vital for enforcement success.
Sources:
[1] South Korea Patent Office (KIPO) Patent Database.
[2] World Intellectual Property Organization (WIPO) PatentScope.
[3] Relevant scientific literature detailing chemical classes and therapeutic applications.
